One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

Authors
Publication date
1 January 2008
Publisher
BioMed Central
Doi
    View on PubMed

    Abstract

    Many patients with chronic obstructive pulmonary disease (COPD) are treated with twice daily (BID) inhaled corticosteroids (ICS). This study evaluated whether daily PM mometasone furoate administered via a dry powder inhaler (MF-DPI) was equally effective compared to twice daily dosing

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Springer - Publisher Connector

      redirect
      Last time updated on 30/04/2017

      Crossref

      redirect
      Last time updated on 05/06/2019

      Springer - Publisher Connector

      redirect
      Last time updated on 05/06/2019

      Directory of Open Access Journals

      redirect
      oaioai:doaj.org/article:1e96a24d7...
      Last time updated on 18/12/2014

      Crossref

      redirect
      Last time updated on 27/12/2021

      University of Nebraska Medical Center Research: DigitalCommons@UNMC

      redirect
      oaioai:digitalcommons.unmc.edu:co...
      Last time updated on 07/10/2025